Article

Intravitreal ranibizumab in the treatment of predominantly hemorrhagic lesions in exudative age-related macular degeneration.

Jules Gonin University Eye Hospital, Lausanne, Switzerland.
Klinische Monatsblätter für Augenheilkunde (Impact Factor: 0.7). 04/2011; 228(4):288-92. DOI: 10.1055/s-0031-1273214
Source: PubMed

ABSTRACT Submacular hemorrhage is a manifestation of neovascular age-related macular degeneration (AMD) that has a very poor natural history leading to severe visual loss. We have evaluated the safety and efficacy of intravitreal ranibizumab in the treatment of predominantly hemorrhagic AMD.
A retrospective study of patients with predominantly hemorrhagic AMD treated with intravitreal ranibizumab at the Jules Gonin Eye Hospital between December 2006 and December 2008 was undertaken. Baseline and monthly follow-up exams included visual acuity (VA), fundus exam and optical coherence tomography (OCT) while fluorescein and indocyanine green angiography were performed at least every three months.
The study included 8 eyes. The mean follow-up was 13 months (SD: 6.3). The mean number of intravitreal injections administered for each patient was 6.4 (SD: 2). 50 % of the patients demonstrated stable or improved VA. The size of hemorrhage at baseline was inversely correlated to the final VA (two-tailed p value = 0.038) and positively correlated to the final central macular thickness (two-tailed p value = 0.021). Anticoagulation treatment was inversely correlated to the time of hemorrhage resolution (two-tailed p value = 0.039).
Intravitreal ranibizumab may be an effective treatment for predominantly hemorrhagic lesions due to neovascular AMD.

0 Bookmarks
 · 
71 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Subretinale Blutungen können als Komplikation verschiedener Erkrankungen entstehen und entstammen entweder der choroidalen oder retinalen Zirkulation. Mit Abstand die häufigste Ursache ist eine choroidale Neovaskularisationsmembran (CNV) bei altersassoziierter Makuladegeneration (AMD), gefolgt von anderen Erkrankungen mit einer CNV und von retinalen arteriellen Makroaneurysmen (RAM). Im Allgemeinen haben subretinale Blutungen eine ernste Visusprognose, wobei es Ausnahmen mit günstigem Spontanverlauf gibt. Das macht die Entscheidung für oder gegen therapeutische Interventionen schwierig. Aufgrund des heterogenen Erscheinungsbildes submakulärer Blutungen wird eine Klassifikation vorgeschlagen, um neue Studienprotokolle zu erstellen und die verschiedenen Therapieoptionen zu bewerten.
    Der Ophthalmologe 109(7). · 0.53 Impact Factor

Full-text

Download
37 Downloads
Available from
Jun 30, 2014